Marietta, Ga.-based Amendia completed a transaction with private equity firm Kohlberg & Company.
Here are five takeaways:
1. Kohlberg & Company has acquired majority ownership of Amendia.
2. The firm plans to support Amendia's growth initiatives with its $1.6 billion private equity fund, Kohlberg Investors VII.
3. Amedica also grew its senior management team:
• Chris Fair as COO and board of directors' member
• Larry Boyd, PhD, as executive vice president of research and development
• Scott Bruder, MD, PhD, as a Kohlberg strategic advisor and a member of Amendia's board of directors and executive committee
4. Amendia entered the partnership to position itself for accelerated growth and enhanced value propositions for customers and partners.
5. Amendia offers products to treat deformity and degenerative conditions.